Prevail Therapeutics Inc. (PRVL) [Rocket]

Date Filed

Type

Description

01/26/2021

ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Unknown transaction of 13,822,463 shares @ $0

01/26/2021

Abeliovich Asa (President & CEO) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Unknown transaction of 2,385,756 shares @ $0
Disposed/sold 1,329,219 options to buy @ $0.18, valued at $239.3k
Disposed/sold 178,681 options to buy @ $10.26, valued at $1.8M
Disposed/sold 250,000 options to buy @ $16.91, valued at $4.2M

01/26/2021

Adams Timothy M (Director) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Disposed/sold 32,400 options to buy @ $10.26, valued at $332.4k
Disposed/sold 17,000 options to buy @ $16.98, valued at $288.7k

01/26/2021

Carson William H. (Director) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Disposed/sold 34,000 options to buy @ $11.11, valued at $377.7k

01/26/2021

Dai Yong (Chief Technology Officer) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Disposed/sold 200,172 options to buy @ $0.18, valued at $36k
Disposed/sold 126,567 options to buy @ $10.26, valued at $1.3M
Disposed/sold 43,500 options to buy @ $16.91, valued at $735.6k

01/26/2021

Hefti Franz (Chief Development Officer) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Disposed/sold 266,895 options to buy @ $0.18, valued at $48k
Disposed/sold 59,844 options to buy @ $10.26, valued at $614k
Disposed/sold 62,200 options to buy @ $16.91, valued at $1.1M

01/26/2021

Kaplan Brett (CFO) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Disposed/sold 347,004 options to buy @ $0.18, valued at $62.5k
Disposed/sold 64,565 options to buy @ $10.26, valued at $662.4k
Disposed/sold 95,000 options to buy @ $16.91, valued at $1.6M

01/26/2021

Minkow Emily (Chief Business Officer) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Unknown transaction of 13,000 shares @ $0
Disposed/sold 149,000 options to buy @ $0.18, valued at $26.8k
Disposed/sold 104,895 options to buy @ $0.18, valued at $18.9k
Disposed/sold 108,854 options to buy @ $10.26, valued at $1.1M
Disposed/sold 54,000 options to buy @ $16.91, valued at $913.1k

01/26/2021

Nader Francois (Director) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Unknown transaction of 23,747 shares @ $0
Disposed/sold 133,447 options to buy @ $2.81, valued at $375k
Disposed/sold 32,000 options to buy @ $10.26, valued at $328.3k
Disposed/sold 17,000 options to buy @ $16.98, valued at $288.7k

01/26/2021

Schwartz Kira M. (General Counsel) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Disposed/sold 100,000 options to buy @ $16.68, valued at $1.7M

01/26/2021

Sevigny Jeffrey (Chief Medical Officer) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Disposed/sold 400,342 options to buy @ $0.18, valued at $72.1k
Disposed/sold 122,439 options to buy @ $10.26, valued at $1.3M
Disposed/sold 89,000 options to buy @ $16.91, valued at $1.5M

01/26/2021

Sheng Morgan (Director) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Disposed/sold 20,000 options to buy @ $10.62, valued at $212.4k
Disposed/sold 17,000 options to buy @ $16.98, valued at $288.7k

01/26/2021

Nussbaum Ran (Director) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Unknown transaction of 1,576,881 shares @ $0
Disposed/sold 17,000 options to buy @ $16.98, valued at $288.7k

01/26/2021

GORDON CARL L (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Unknown transaction of 13,822,463 shares @ $0
Disposed/sold 17,000 options to buy @ $16.98, valued at $288.7k

01/26/2021

Thompson Peter A. (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Unknown transaction of 13,822,463 shares @ $0
Disposed/sold 17,000 options to buy @ $16.98, valued at $288.7k

01/22/2021

Tyto Acquisition Corp (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Bought 34,284,789 shares @ $22.5, valued at $771.4M

12/31/2020

Abeliovich Asa (President & CEO) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Paid exercise price by delivering 89,037 shares @ $23.02, valued at $2M
Exercised 5,256 options to buy @ $0.18, valued at $946.1
Exercised 120,537 options to buy @ $10.26, valued at $1.2M

12/16/2020

Tyto Acquisition Corp (10% Owner) has filed a Form 3 on Prevail Therapeutics Inc.

09/11/2020

Form 4 - Statement of changes in beneficial ownership of securities:

09/11/2020

Form 3 - Initial statement of beneficial ownership of securities:

06/19/2020

Thompson Peter A. (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.

Txns:

Granted 17,000 options to buy @ $16.98, valued at $288.7k

06/19/2020

Sheng Morgan (Director) has filed a Form 4 on Prevail Therapeutics Inc.